IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v39y2016i1d10.1007_s40264-015-0367-8.html
   My bibliography  Save this article

Advances in the Pharmacogenomics of Adverse Drug Reactions

Author

Listed:
  • Susannah L. Collins

    (University of Liverpool)

  • Daniel F. Carr

    (University of Liverpool)

  • Munir Pirmohamed

    (University of Liverpool)

Abstract

Rapid developments in pharmacogenomics have been noticeable in recent years, and much of this knowledge has improved understanding of adverse drug reactions. This improved knowledge has largely been the result of improved sequencing technologies and falling costs in this area, as well as improved statistical techniques to analyse the data derived from studies. While the genetic reasons behind adverse drug reactions are becoming better understood, translation of this knowledge, particularly in terms of biomarkers that might be clinically applicable at the bedside, has been more difficult. Understanding of the technologies and their application is limited among practising clinicians. The cost of some of the technologies available may also be prohibitive in stretched healthcare economies. As education about the potential for applying pharmacogenomics improves and costs fall, understanding of adverse drug reactions and application of this knowledge in a clinical setting should improve.

Suggested Citation

  • Susannah L. Collins & Daniel F. Carr & Munir Pirmohamed, 2016. "Advances in the Pharmacogenomics of Adverse Drug Reactions," Drug Safety, Springer, vol. 39(1), pages 15-27, January.
    • Handle: RePEc:spr:drugsa:v:39:y:2016:i:1:d:10.1007_s40264-015-0367-8
    DOI: 10.1007/s40264-015-0367-8
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-015-0367-8
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40264-015-0367-8?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Qun-Ying Yue, 2021. "The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance," Drug Safety, Springer, vol. 44(6), pages 615-617, June.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:39:y:2016:i:1:d:10.1007_s40264-015-0367-8. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.